miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator

Daisuke Yamashita1, Toru Kondo2, Shiro Ohue3

  • 1Department of Neurosurgery, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

Cancer Research
|January 29, 2015
PubMed

Related Concept Videos